Bard C R (NYSE:BCR)
Historical Stock Chart
5 Years : From Apr 2012 to Apr 2017
C.R. Bard Inc. (BCR) disclosed Tuesday that its Davol Inc. subsidiary has voluntarily recalled a surgical-graft product called XenMatrix that is used in hernia and abdominal wall repair.
The medical-device maker said its previously issued guidance for the fourth quarter last year and full-year this year remains unchanged despite the recall.
The company disclosed the event in a brief filing with the Securities and Exchange Commission, where it said the recall started on Friday. It did not describe a reason for the recall, and a spokesman could not be reached for immediate comment on the matter.
Bard's shares traded up 26 cents to $91.31 early Tuesday.
-By Jon Kamp, Dow Jones Newswires; 617-654-6728; email@example.com